Serum sCD36 levels have been correlated with tissue CD36 expression and are elevated in patients with type 2 diabetes mellitus (T2DM), especially those with lipid-induced renal injury and inflammation (7, 8), suggesting its potential as a non-invasive biomarker of DKD progression. The gene discussed is CD36; the disease is type 2 diabetes mellitus.